Population Structure and Antimicrobial Susceptibility of Both Nonpersistent and Persistent Pseudomonas aeruginosa Isolates Recovered from Cystic Fibrosis Patients

Eitemau Tebyg

• Breakpoints for Predicting Pseudomonas aeruginosa Susceptibility to Inhaled Tobramycin in Cystic Fibrosis Patients: Use of High-Range Etest Strips
  gan: Morosini, María I., et al.
  Cyhoeddwyd: (2005)
• PCR-Based Assay for Differentiation of Pseudomonas aeruginosa from Other Pseudomonas Species Recovered from Cystic Fibrosis Patients
  gan: Spilker, Theodore, et al.
  Cyhoeddwyd: (2004)
• Emergence of a mutL Mutation Causing Multilocus Sequence Typing–Pulsed-Field Gel Electrophoresis Discrepancy among Pseudomonas aeruginosa Isolates from a Cystic Fibrosis Patient
  gan: García-Castillo, María, et al.
  Cyhoeddwyd: (2012)
• Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics
  gan: Ekkelenkamp, Miquel B., et al.
  Cyhoeddwyd: (2020)
• Molecular identification of Pseudomonas aeruginosa recovered from cystic fibrosis patients
  gan: DOURAGHI, M., et al.
  Cyhoeddwyd: (2014)